STAT3 and neoplasm: Evidence has shown that activation of STAT3 stimulated by IL-10 and TGFβ in tumor-infiltrating DCs impedes CD8+ T cell function, and contributes to accumulation and proliferation of tolerogenic Treg cells inside tumors [123].